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 Substance use and misuse in burn patients: testing the classical hypotheses of the 
interaction between posttraumatic symptomatology and substance use 
 
Background: We aimed to test whether the three classical hypotheses of the interaction 
between posttraumatic symptomatology and substance use (high risk of trauma 
exposure, susceptibility for posttraumatic symptomatology, and self-medication of 
symptoms), may be useful in the understanding of substance use among burn patients. 
Methods: We analysed substance use data (nicotine, alcohol, cannabis, amphetamines, 
cocaine, opiates, and tranquilizers) and psychopathology measures among burn patients 
admitted to a Burns Unit and enrolled in a longitudinal observational study. Lifetime 
substance use information (n=246) was incorporated to analyses aiming to test the high 
risk hypothesis. Only patients assessed for psychopathology in a six months follow-up 
(n=183) were included in prospective analyses testing the susceptibility and self-
medication hypotheses. 
Results: Regarding the high risk hypothesis, results show a higher proportion of heroin 
and tranquilizer users compared to the general population. Furthermore, in line with the 
susceptibility hypothesis, higher levels of symptomatology were found in lifetime 
alcohol, tobacco and drug users during recovery. The self-medication hypothesis could 
be tested partially due to the hospital stay “cleaning” effect, but severity of symptoms 
was linked to caffeine, nicotine, alcohol and cannabis use after discharge. 
Conclusions: We found that the three classical hypotheses could be used to understand 
the link between traumatic experiences and substance use explaining different patterns 
of burn patient’s risk for trauma exposure and emergence of symptomatology. 
Key words: Burn patients, substance use, substance misuse, trauma, coping strategies, 
self-medication. 
 Introduction 
Substance use and misuse among burn patients 
Until now, substance use and misuse among burn patients has been an understudied 
feature in this population. Although it could be considered a secondary factor into the 
complexity of the burn recovery process (usually including painful surgery and physical 
rehabilitation), previous research evidences the high rates of substance use among 
patients admitted to burn units 1–4, the specific recovery difficulties of patients with 
substance misuse problems 5–7, and the higher rates of PTSD among burn patients with 
previous substance use disorders 8.  
High, although variable rates of substance misuse, have been detected in clinical 
studies measuring it as primary or secondary outcome. Alcoholism was proposed as the 
most reliable predisposing factor in a classical study carried by MacArthur and Moore 9. 
McKibben et al. 1 reviewed rates of alcohol and substance use disorders in different 
samples of patients admitted to burn units. Alcohol misuse rates among participants of 
burn studies seem to be high (32-41%) although comparisons with the general 
population are not always feasible, as the methodologies used are different from 
population-wide studies. Furthermore, drug misuse have different rates in studies made 
in different countries (6-24%). These results may respond to different drug cultures and 
the methodologies used. 
Differences with the general population regarding substance use can be seen in 
studies such as the one carried by Fauerbach et al. 10. This study group found higher 
lifetime and follow-up rates for alcohol and drug abuse and dependence among burn 
injured adults compared to a community-dwelling sample. Accordingly, higher rates of 
substance use disorders are shown by Meyer et al. 11, who compared young adults who 
suffered burn injuries during childhood, with the US population of comparable age. 
 All this information taken together, suggests an influence of substance misuse as a 
possible cause of the injury and, subsequently, an aggravating condition in patients’ 
recovery. It may also be assumed that burn injuries may lead to substance use, however, 
the lack of longitudinal data has prevented analyses in this regard. 
Shared pathways of trauma and substance use 
Despite the lack of information about substance use among burn patients, 
interaction of trauma and substance use has been extensively studied in general and 
specific samples of traumatized patients. In a classical revision, Brown and Wolfe 2 
proposed three mechanisms by which traumatic stress and substance use disorders may 
interact: 1) substance users’ higher risk of exposure to traumatic events, 2) substance 
users’ increased susceptibility to psychiatric disorders due to deteriorating physical and 
psychological conditions, and 3) the use of drugs as self-medication of posttraumatic 
symptoms. The high risk hypothesis, postulates that substance users are more prone to 
risky behaviours (e.g. theft or dangerous driving), which increase the probability of 
exposure to potentially traumatizing events. The susceptibility hypothesis postulates 
that the vulnerability to comorbid substance use disorders and PTSD is due to persistent 
changes in physiology and neurochemical systems because of substance misuse, or a 
complex interplay between all of the above. Finally, the self-medication hypothesis 
postulates that PTSD develops first and substances are used as a means of achieving 
symptom relief. In other prominent revisions, these three hypotheses appear as the 
principal pathways by which trauma and substance use and misuse interact 12,13, having 
been tested in some empirical works. For instance, Chilcoat and Breslau 14,15 tested the 
three hypotheses in an epidemiological study of young adults. They found support for 
the use of substances to self-medicate symptoms among persons suffering from PTSD, 
no support for the high risk hypothesis, and they could not rule out the possibility of 
 shared vulnerability to PTSD and drug use. However, it has been long advocated that 
substance misuse makes people more vulnerable to accidents such as burns 16,17. 
Recent works show support for the three models. The high risk hypothesis 
receives evidence from epidemiological 16 and family genetic studies 17, and the 
susceptibility hypothesis mainly from neurobiological and genetic studies  18,19. The 
self-medication hypothesis has received support mainly from clinical 20 and 
epidemiological studies 21–23. 
To our knowledge, to date no study has longitudinally assessed the interaction 
between injury conditions, posttraumatic symptomatology and recovery characteristics 
with substance use within a sample patients admitted to a burn unit. In this study we use 
information extracted from an extensive clinical sample of burn patients to test the three 
hypotheses proposed by Brown and Wolfe 2: the high risk hypothesis, the susceptibility 
hypothesis and the self-medication hypothesis. Our expectation is that all three will shed 
some light on how trauma interacts with substance use in this group of survivors. 
 
Methods 
Sample. 
All adult patients (n=246) screened in the Burn Unit of the University Hospital Vall 
d'Hebron during a period of two years were incorporated to baseline analyses aiming to 
test the high risk hypothesis. From this sample, with the objective of testing the 
susceptibility and self-medication hypotheses, 183 patients were included in prospective 
analyses after applying the following exclusion criteria: a) not enough Spanish/Catalan 
language proficiency; b) Mini-Mental State Examination <23; c) decease and, d) 
recruitment limitations (i.e. not reached, short admissions or admission for long term 
sequelae). No patient explicitly withdrawn consent once included in the study.  This 
 study was performed according to the guidelines of the Helsinki Declaration 24. The 
ethical committee of the hospital approved the protocol and all patients signed an 
informed consent. Participation was confidential and on a voluntary basis. A flowchart 
of the study can be seen in figure 1. 
Figure 1. Flow diagram of the study 
 
Patients admitted to the Burns unit between 
April 2009 and June 2011 with second and third 
degree burns (n=489) 
Less than 18 or more than 75 years of 
age (n=106). 
Baseline assessment (n=183) 
 
Target population (n=383) 
Full lifetime substance use information available 
for 243 patients 
Patients completed all 6 assessments (n=119) 
7 days (n=143) 
14 days (n=159) 
21 days (n=174) 
30 days (n=180) 
90 days (n=173) 
180 days (n=165) 
 Not enough language 
proficiency (n=60) 
 Withdrawal of consent (n=31) 
 Mini-Mental State Examination 
<23 (n=14) 
 Death (n=11) 
 Not reached, short admissions, 
sequelae (n=84). 
 Procedure. 
In this follow-up study, participants between 18 and 75 years of age were 
assessed by two trained psychologists consecutively at six different stages: once a week 
during the first month after burn injury (for acute stress symptomatology), once more at 
three months (when posttraumatic stress disorder, PTSD, is considered to became 
already chronic), and again at six months (for delayed onset of posttraumatic symptoms) 
after the injury. The assessments were conducted face to face in the case of hospital 
interviews and by telephone when participants were already discharged. 
Measures. 
Sociodemographic information, previous health (including mental health) 
problems and burn data were collected at first assessment, or when the recovery of the 
patient allowed it, using an ad-hoc structured interview and also at the six months 
follow-up. Substance use information, depressive, anxiety and traumatic stress 
symptoms, as well as positive and negative emotions were assessed, whenever possible, 
at every one of the six consecutive assessments. Both lifetime and longitudinal (at 7, 14, 
30, 90 and 180 days) substance use was recorded for nicotine, alcohol, cannabis, 
amphetamines, cocaine, opiates, and tranquilizers, using a brief ad-hoc inventory. 
Regarding the latter, reasons of consumption were also inquired about (use under 
medical supervision vs. unsupervised tranquilizer use). 
Additionally, the COPE 25 was used to assess lifetime substance use coping 
strategies at baseline. This questionnaire measures a variety of coping behaviours. It has 
demonstrated good psychometric properties assessing 12 coping behaviours including: 
self-distraction, active coping, denial, substance use, use of emotional support, 
behavioural disengagement, venting, positive reframing, planning, humour, acceptance, 
and religion. The substance use scale, assesses the alcohol or drug disengagement as a 
 way of coping, e.g. I drink alcohol or take drugs, in order to think about it less. This 
instrument has been used in stress related studies including burn survivors26. 
At all six assessments depression was measured using the Beck Depression 
Inventory, BDI 27,28. This 21-question self-report inventory is probably the most widely 
used psychometric test for measuring the severity of depression, which increases 
comparability with other studies made on burn injuries or other medical conditions. 
Also anxiety was measured at all assessments using the State Trait Anxiety Inventory, 
STAI 29, a commonly used inventory of trait and state anxiety consisting of 40 questions 
on a self-report basis. This questionnaire allows the differentiation of anxiety as a 
personality trait, with anxiety related to the fluctuation of patients’ recovery. Anxiety 
trait only was measured at baseline. 
In relation to posttraumatic stress symptoms, the revision of the Impact of 
Events Scale, IES-R 30 was administrated to measure avoidance, intrusion and 
hyperarousal responses to trauma at all six assessments. This instrument was chosen 
because of its psychometric properties and its validated three factor structure in burn 
patients 31. The Davidson Trauma Scale, DTS 32, an instrument with a reliable cut-off, 
was used to measure posttraumatic symptoms severity and frequency at 30, 90 and 180 
days. Previous studies in burn patients have used this scale as a successful measure of 
posttraumatic symptomatology 33. Additionally, the MINI international neuropsychiatric 
interview 34, Spanish version 35, was used at six months to perform a clinical assessment 
of PTSD following DSM IV criteria. Similar than other diagnostic instruments, such as 
the Structured Clinical Interview for DSM and the Composite International Diagnostic 
Interview, it has showed appropriate psychometric properties 36, and it has already been 
successfully used in burn research to assess PTSD 37. 
 
 The Positive and Negative Affect Schedule, PANAS 38, was used for the measure of 
positive and negative emotions also in the last three assessments. This self-administered 
scale contains 20 multiple-choice items on a five-point scale ranging from 1 = Very 
Slightly or Not at All, to 5 = Extremely. It assesses the extent to which the respondent 
have felt that way over the past week, including items of negative affect (such as upset, 
guilty or scared) as well as items of positive affect (such as enthusiastic, interested or 
proud). This instrument has shown good psychometric properties 39. In this study, the 
sum of negative items was subtracted to the sum of positive items, so the result 
expresses a positive emotional direction, ranging -40 – 40. 
In summary, all these instruments have been demonstrated to be valid and reliable in 
burn patients research40. 
Data analysis 
Available sociodemographic (including age, gender, cohabitation, education, work 
status, and socioeconomic status) and burn characteristics (including total body burn 
surface [TBSA], aetiology, mechanism, place of occurrence and the presence of other 
persons in the burn scene) were compared between patients with and without lifetime 
substance use by means of t tests for continuous variables (Mann–Whitney Us if sample 
size was not enough to perform a parametric test), and odds ratios for categorical 
variables. 
The high risk hypothesis was tested comparing lifetime substance use rates of 
patients with representative Spanish population data collected using the same questions 
(i.e. have you ever consumed…) in the period when the study was done 41,42 using Chi-
squared tests with Bonferroni adjustments for multiple comparisons, expecting that 
some of the proportions will be statistically higher in our sample than in the equivalent 
general population. As our sample is representative of the population of severe burns in 
 a region, the possible overrepresentation of the use of a given substance could indicate 
that behaviours associated with the use of these substances may lead to an increased risk 
of burn injuries. 
The susceptibility hypothesis was tested in two ways. Firstly we checked whether 
substance use as a coping strategy (a subscale of the COPE questionnaire) correlated 
with posttraumatic symptomatology, anxiety, depression and positive emotions 
measured in the mentioned six follow up interviews. As the distribution of the COPE 
subscale was skewed to the left, correlations were made using non-parametric 
Spearman's rank correlation coefficients.  
Secondly we wanted to prove that the emergence of symptoms could be caused by 
lifetime alcohol and illegal substance misuse. Due to the structure of our data, multiple 
imputations were used to manage missing data and perform t-tests and repeated 
measures general linear models (RM-GLMs) using substance misuse (lifetime 
problematic use of alcohol, i.e. ≥4 consumption units of alcohol/day, each unit=10 g of 
alcohol 43; and/or lifetime consumption of illegal substances) as independent variable, 
and symptomatology and positive emotions as dependent variables. Tobacco 
consumption was analysed separately. As there was a very high rate of absolute lifetime 
consumption and current irregular consumption of tobacco in our sample, regular 
smoking (ten or more cigarettes per day) at the time of the injury was used as 
independent variable to perform t-tests and RM-GLMs with symptomatology and 
positive emotions as dependent variables. The rates of PTSD at six months were 
compared by lifetime misuse of alcohol and/or lifetime consumption of illegal 
substances and regular smoking using odds ratios.  
 
 Finally, the self-medication hypothesis was tested correlating levels of substance use 
and posttraumatic symptomatology in each follow up interview (if information was 
available and we were able to gather a sufficient number of consumers), using non-
parametric Spearman correlations due to the generalized left skewness of score 
distributions and low n. Due to sample n and admission characteristics restrictions (any 
substance use was restricted excluding tobacco), we were only able to test nicotine 
during the whole study, alcohol at 30, 90, and 180 days and cannabis at 180 days. We 
expected positive correlations between symptomatology and substance use after the 
injury. 
All analyses were at the 95% confidence interval level, and were performed using 
the SPSS 18.0 statistical package. 
 
Results 
From a total of 383 patients between 18 and 75 years of age admitted to the burn 
unit, full lifetime information for drug use was available for 243 (63.4% of the total 
sample) and prospective psychopathological data was available for 183 patients. 
Patients reporting any lifetime substance misuse (problematic use of alcohol and/or any 
illegal substance use, as described in the data analysis section) were more likely to drop 
out from the study at any of the measurement points (OR: 2.67, 95% IC=5.03—1.42).  
Participants’ mean age was 41.14 (SD = 14.13), 29% were females, 68.3% were in a 
relation, 55.7% had at least secondary studies and the same percentage were considered 
to be professionally active. However, 23% of the sample reported a low economic 
income situation. Their mean TBSA burned was 14.1% (SD = 13.97) and the average of 
length of stay was 20.96 days (SD = 20.36). From the sample, 31.1% suffered third-
degree burns. Most burns were caused by flame (61.7%) followed by scalds (18.5%). A 
 total of 14 patients (5.8% of the sample) had a lifetime history of heroin and cocaine 
dependence (no patient was found to have lifetime history of heroin dependence without 
cocaine dependence).  
Patients characteristics by substance use type 
Lifetime smokers (n=173, 64.8%) were more likely to be men (OR=1.88, 95% 
C.I.=1.09-3.22, p=.022), unemployed (OR=.55, 95% C.I.=.32-.96, p=.034) and involved 
in a flame or electric accident (in contrast to accidents due to chemicals, scalds or 
contact with surfaces, (OR=2.26, 95% C.I.=1.33-3.81, p=.002) than patients reporting 
no lifetime nicotine use. Lifetime alcohol drinkers (n=180, 70.9%) were more likely to 
be men (OR=4.03, 95% C.I.=2.26-7.18, p<.0001) and more likely to have had an 
accident in a public place (vs. home, OR=1.80, 95% C.I.=1.03-3.14, p=.037) than 
people reporting no lifetime misuse of alcohol. 
Amphetamine users (n=9, 3.7%) were younger than non-users (z=-2.403, p=.016) 
and also had more likely been burned in a public place (OR=9.11, 95%, C.I.=1.12-
74.02, p=.016). Lifetime cannabis users (n=48, 20%) were younger (t=-5.025, p<.0001), 
more likely men (OR=2.68, 95%, C.I.=1.19-6.06, p=.015), had a lower socioeconomic 
status (OR=2.32, 95%, C.I.=1.16-4.62, p=.016), and had been burned with flame or 
electricity (OR=2.24, 95%, C.I.=1.11-5.31, p=.002). 
Cocaine users (n= 29, 11.9%) were younger (t=-2.615, p=.009), more likely to be 
living alone (OR=.42, 95%, C.I.=.179-.982, p=.041), unemployed (OR=.28, 95%, 
C.I.=.12-.67, p=.003), had a lower socioeconomic status (OR=5.35, 95%, C.I.=2.32-
12.33, p<.0001), and have been more likely burned with flame or electricity (OR=3.37, 
95%, C.I.=1.13-1.08, p=.022) than non-lifetime cocaine users. 
 
 Opiate users (n=14, 5.8%) were more often unemployed (OR=.06, 95% 
C.I.=.01-.48, p<.0001), living alone (OR=.28, 95% C.I.= .09-.88, p=.022), had a lower 
socioeconomic status (OR=6.44, 95% C.I.=.82-50.45, p<.05), and were more likely to 
have been involved in a flame or electric accident (OR=6.44, 95% C.I.=.82-50.45, 
p=.043), than non-lifetime opiate users. All these patients had once received a diagnosis 
of opioid dependence before the injury. 
Tranquilizers users (n=51, 21.4%) were more often living alone (OR=.47, 95% 
C.I.=.28-.963, p=.037), unemployed (OR=.24, 95%, C.I.=.12-.50, p<.0001), had a lower 
socioeconomic status (OR=2.54, 95%, C.I.=1.26-5.11, p=.008) and were less likely to 
be involved in an accident with more injured people (OR=.32, 95%, C.I.=.11-.94, 
p=.029). The reasons for consumption were exclusively mental health problems for the 
80% of the sample, and combination with other drugs (mainly opiates) for the 
remaining 20%. 
High risk hypothesis. 
The results of the analysis of the high risk hypothesis can be seen in table 1. As 
said in the analysis section, rates in the sample were compared to Spanish national 
representative data. The basic demographic characteristics of our sample were similar in 
terms of mean age (41 years of age in our sample, 40 in the local general population), 
although not of genre distribution (with a higher proportion of men in our sample). 
Therefore we have included a stratification by gender. Statistical significant differences 
between our sample and the general population were found for alcohol in the case of 
men, tobacco among men, cannabis in both genders, opiates in both genders and 
tranquilizers. After Bonferroni adjustment, statistical signification remained only for 
opiates and tranquilizers in both genres. 
 Table 1. Lifetime prevalence (%) of substance use in our sample (n=246) compared to 
Spain population* 
  Population estimate Burn patients Significance 
Alcohol** Total 63.3 70.9 

2
=6.259, p=.012 
 Men 73.3 80.1 

2
=4.175, p=.041 
 Women 50 50 

2
=.000, p=1 
Tobacco Total 68.5 64.8 

2
=1.699, p=.192 
 Men 75.5 69.1 

2
=4.100, p=.043 
 Women 63.3 54.4 

2
=2.675, p=.102 
Cannabis Total 27.3 20.0 

2
=6.444, p=.011 
 Men 36.8 24.2 

2
=11.187, p=.001 
 Women 20.1 10.7 

2
=4.156, p=.041 
Cocaine Total 8.0 11.9 

2
=5.110, p=.024 
 Men 10.5 12.6 

2
=0.765, p=.382 
 Women 3.4 10.5 

2
=11.751, p=.001 
Opiates Total .8 5.8 

2
=75.370, p<.0001 
 Men 1.1 6.0 

2
=525.127, p>.0001 
 Women .2 5.3 

2
=97.610, p>.0001 
Amphetamines Total 3.8 3.7 

2
=.006, p=.937 
 Men 5 4.2 

2
=.230, p=.632 
 Women 1.8 2.6 

2
=.297, p=.586 
Tranquilizers Total 13 21.4 

2
=14.999, p<.0001 
 Men 10.04 18.9 

2
=14.442, p<.0001 
 Women 15.02 27.0 

2
=277.813, p<.0001 
Bonferroni adjustment for multiple comparisons: .05/7=.007. *EDADES[Encuesta Domiciliaria sobre Alcohol y 
Drogas en España] studies 41  **At least a lifetime frequent drinking period.
 Susceptibility hypothesis 
Substance use as a coping strategy. 
The correlations of the substance use subscale of the COPE questionnaire with 
posttraumatic symptomatology at the six follow up points can be seen in table 2. No 
statistically significant correlations were found for avoidance. Moderate to low 
statistically significant correlations were found for intrusion at all points and 
hyperarousal at 14, 21 days and three months. Posttraumatic symptoms severity and 
frequency, was found to statistically correlate with high levels of substance use coping 
style at 30 days and 3 months. Anxiety correlated significantly at 14, 21, 30 days and 
three months, while depression correlated at all-time points excluding the six months 
follow-up. Positive and negative emotions (in a single punctuation recoded to positive) 
negatively correlated at 3 and 6 months. 
  
 Table 2. Pearson correlations of the drug use subscale of the COPE questionnaire with 
posttraumatic symptomatology 
 7 days 14 days 21 days 30 days 3 
months 
6 
months 
IES-R Avoidance .040 .031 .036 .011 .134 .003 
IES-R Intrusion .192* .245** .174* .164* .158* .160* 
IES-R 
Hyperarousal 
.163 .207** .214** .051 .170* .084 
DTS score - - - .183* .202** .128 
STAI state score .038 .231** .270*** .169* .155* .133 
BDI score .313** .203* .232** .179* .172* .149 
PANAS - - - -.127 -.189* -.169* 
*p<.05, **p<.01, p<.001 
IES-R: Impact of Events Scale Revised, DTS: Davidson Trauma Scale, STAI: State Trait Anxiety 
Inventory, BDI: Beck Depression Inventory, PANAS: Positive and Negative Affect Schedule (negative 
items were recoded so the result is in a positive emotional direction
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Emergence of symptoms by lifetime alcohol and illegal substance misuse. 
The emergence of symptomatology by lifetime alcohol and/or illegal substance 
misuse compared with no lifetime misuse can be seen in figures 2 and 3. Anxiety and 
depression had similar evolutions in both groups, although scores were higher across the 
evolution for patients with substance use problems. Hyperarousal was higher at the beginning 
among misusers, tended to converge, and had a final upturn in the misusers group. Intrusion 
was higher in the acute phase for misusers but it tended to converge. Avoidance had virtually 
identical evolutions in both groups. Positive emotions grew in the non-misusers group while 
decreased in the misusers group. Posttraumatic symptomatology measured with the DTS was 
higher at all assessments. 
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Figure 2. Evolution of symptomatology by lifetime substance misuse * (n=183). 
 
Substance misuse: lifetime problematic use of alcohol (≥4 consumption units of alcohol/day, each unit=10 g of alcohol 43) and/or lifetime consumption of illegal substances, 
BDI: Beck Depression Inventory, STAI: State Trait Anxiety Inventory, IES: Impact of Event Scale. The maximums and minimums for all figures have been adapted to the 
average ranges in our sample. Theoretical ranges for the scales in this figure are STAI: 0 – 60, BDI: 0 – 63, IES: each item ranges 0 – 4, total scores are divided by the 
number of items, and thus the theoretical range is the mean (0 – 4).
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Figure 3. Evolution of posttraumatic stress and positive emotions by lifetime substance misuse (n=183). 
 
 
 
 
 
 
PANAS: Positive and Negative Affect Schedule, DTS: Davidson Trauma Scale. * Theoretical ranges for the scales in this figure are PANNAS: -40 – 40 
(negative emotions items subtracted to positive emotions), DTS: 0 –136. 
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Bivariate differences between groups were statistically different (t-tests) for STAI trait 
(t=3.602, p<.0001); STAI state at 21 (t=2.465, p=.015), 90 (t=2.135, p=.034) and 180 days 
(t=2.777, p=.006); BDI at 90 (t=2.227, p=.027) and 180 (t=2.840, p=.005) days. Regarding 
posttraumatic symptomatology, avoidance (t=2.002, p=.047) and DTS (t=2.460, p=.015) 
were statistically different at 180 days. Positive emotions measured by the PANAS were 
significantly different at 90 (t=-2.082, p=.041) and 180 (t=-2.177, p=.031) days. The results 
of the RM-GLMs showed no statistical differences (multivariate, linear or quadratic) in the 
evolution of symptomatology. No statistically significant difference was found for PTSD at 
six months measured with the MINI interview. 
Emergence of symptoms by regular tobacco consumption. 
Regarding tobacco, baseline regular use was tested using a cut-off of ten cigarettes a 
day (n=72, 39.3% of the sample, 70.6% of the people with any tobacco use). The evolution of 
symptomatology by regular tobacco use can be seen in figures 4 and 5. Anxiety, depression, 
intrusion and avoidance had similar evolutions in both groups. As in the case of alcohol or 
drug misuse, hyperarousal was higher at the beginning among smokers, tended to converge, 
and had a final upturn in the regular smoker group. Posttraumatic symptomatology measured 
with the DTS was higher at all assessments and tended to increase in the regular smoker 
group while it decreased in the no regular smoking group. Positive emotions grew and then 
stayed stable in the non-smokers group, while stayed stable and lower in the smoker group.
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Figure 4. Evolution of symptomatology by regular tobacco use* (n=183). 
 
*Regular tobacco use: ten or more cigarettes per day 
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Figure 5. Evolution of posttraumatic stress and positive emotions by regular tobacco use (n=183). 
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Student’s t-tests showed statistically significant differences between smokers 
and non-smokers for STAI trait (t=2.940, p=.004); STAI state at 7 (t=2.940, p=.004), 14 
(t=3.693, p<.0001), 90 (t=2.198, p=.030) and 180 days (t=2.827, p=.005); BDI at 7 
(t=2.082, p=.039), 14 (t=2.398, p=.018), 21 (t=2.134, p=.035), and 180 (t=2.353, 
p=.020) days. Regarding posttraumatic symptomatology, activation at 7 (t=2.202, 
p=.029), 14 (t=2.338, p=.020), 30 (t=2.132, p=.036) and 180 (t=2.280, p=.025) days, 
intrusion at 30 (t=2.606, p=.011) days and DTS at 90 (t=1.983, p<.05) and 180 (t=2.549, 
p=.012) days, were statistically different. Positive emotions were significantly different 
at 90 (t=-2.018, p=.046) and 180 (t=-1.965, p<.05) days. The results of the RM-GLMs 
showed statistical differences in the linear evolution of posttraumatic symptomatology 
measured by the DTS (F=4.234, p=.041). Regular smokers were more likely to develop 
PTSD at six months (55.9% vs. 33.3% for non-regular smokers, OR=2.53, 95%, 
C.I.=1.18-5.46, p=.016). 
Self-medication hypothesis. 
The number of cigarettes smoked did not significantly correlate with any 
psychometric measure in the first 5 assessments, except for a moderate correlation with 
posttraumatic symptomatology measured with the DTS at 30 days (ρ=.251, p<.05). 
Nevertheless, among the total 71 patients reporting any tobacco use at six months, its 
daily amount significantly correlated with anxiety (ρ=.366, p=.002), depression (ρ=.247, 
p=.038), posttraumatic symptomology (ρ=.247, p=.038) and inversely with positive 
emotions (ρ=-.325, p=.006). 
A total of 28, 73 and 83 patients reported any alcohol consumption at one, three 
and six months (it could only be measured at these points due to its prohibition during 
admission). Consumption units significantly correlated with anxiety at 90 days (ρ=.250, 
p=.033). Furthermore, it correlated with activation (ρ=.232, p=.035), anxiety (ρ=.258, 
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p=.018), depression (ρ=.296, p=.007), posttraumatic symptomology measured with the 
DTS (ρ=.238, p=.030) and inversely with positive emotions (ρ=-.324, p=.004) at six 
months. Due to the low number of consumers, cannabis dose could only be tested at 180 
days among 20 patients, finding a statistically significant correlation with avoidance 
(ρ=.453, p=.045). 
Discussion 
The results of the different parts of the analysis lead us to think that people who 
misuse substances both before the accident, and during the recovery phase have a 
distinct symptomatic pattern. 
In the first place, patients with lifetime use of different substances had specific 
profiles of sociodemographic and burn characteristics corresponding generally to 
unemployed males involved in high risk accidents. In other studies, pre-existing and 
burn-related disturbances have been found associated to employment status before the 
burn injury 44. Authors often argue that being unemployed at the time of the burn injury, 
was associated with previous alcohol dependence, illegal substance use and/or misuse 
of psychiatric medication the year before 10,45. 
Regarding the high-risk hypothesis, substances found to be more prevalent in 
our sample than in the Spanish general population (opiates and tranquilizers). Among 
patients reporting these consumptions, we could identify profiles corresponding to our 
daily practice impressions. In the case of opiate users, unemployment, low 
socioeconomic status, living alone, and flame or electric accidents may corresponded to 
current opiate consumers or patients in methadone maintenance treatment, performing 
risky behaviours usually related with illegal activities in the streets (e.g. copper theft). 
In our case, the fourteen patients with current or past opiate consumption met exactly 
this profile. The correct treatment of trauma patients with opiate consumption has been 
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widely stressed. In this regard, special treatments have been established for methadone 
maintained patients suffering from PTSD 46. Fortunately, our team had an experienced 
clinical psychiatrist with a long experience in dual disorders and therefore, maintenance 
treatment could be established or continued controlling carefully the possible 
interactions with burn injury pharmacological treatment, based often in opioids. 
The profile of tranquilizer users corresponded also with unemployment, 
loneliness and low socioeconomic status. However, in contrast to opiate misusers, they 
were more likely to be involved in accidents with no more injured people. Moreover, 
lower rates for electric and flame injuries were found among this group. Although the 
group of patients consuming tranquilizers was heterogeneous (some tranquilizer 
consuming patients also consumed opiates) these data may correspond to forgetful 
patients affected by tranquilizers’ side effects. 
The results of the susceptibility hypothesis showed moderate to low correlations 
between the COPE substance use subscale and some psychometric measures, especially 
at 30 and 90 days. We also found increased levels of symptomatology and negative 
emotions according to all psychometric measures analysed by regular tobacco use. For 
the latter, rates of PTSD at six months were higher and the evolution of posttraumatic 
symptomatology had a divergent evolution compared with the non-smokers group. 
Results according to lifetime substance misuse were much more modest, but also 
reflected a greater presence of symptoms. This constitutes a possible confirmation of 
this hypothesis in a very specific clinical context, which is in line with other recent 
epidemiological studies 21. 
Finally, although sample limitations prevented us from performing longitudinal 
analyses, correlations of symptomatology with substance use at six months reflect 
support for the self-medication hypothesis. Data on alcohol and tobacco may support 
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the theory that the use of substances among these patients is motivated by the levels of 
symptomatology. In this sense, substance use may be seen as a way of coping with 
symptoms. It is nonetheless interesting our results regarding cannabis use. The levels of 
cannabis consumption at six months did significantly and largely correlate with 
avoidance. Although a bigger sample and longitudinal analyses may yield more reliable 
results, the large effect size of this correlation, may correspond with people using 
cannabis as an additional avoidant strategy. 
All these results underscore the importance of screening past and prospective 
substance use amongst burn, and more broadly, traumatised patients, due to the high 
rates of substance use and misuse in these patients and its prognostic implications. Also 
we should note the need of specialised treatments for patients using substances as a way 
to cope with symptoms. 
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